Scholar Rock (SRRK) Stock: Buy, Sell, or Hold?
SRRK - Scholar Rock Holding Corporation Common Stock
$55.41
-0.26 (-0.47%)
âŧ
5d:
-0.95%
30d:
+2.95%
90d:
+23.99%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 9, 2026 at $54.62 · last confirmed Sep 9, 2026
Strength: 5.6/10
Get Alerted When SRRK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SRRK is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SRRK is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SRRK is currently trading at $55.41, which is considered fair relative to its 30-day fair value range of $51.06 to $57.91.
Technical Outlook: Technically, SRRK is in a strong uptrend. The price is currently testing key support at $53.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SRRK scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRRK is in a strong uptrend. The price is currently testing key support at $53.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SRRK scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$51.06 -
$57.91
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
Protect Your Profits
Holding SRRK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($60.75)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$51.06 -
$57.91
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$53.86
Resistance Level
$59.30
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-21.55
Wall Street Target
$60.75
(+9.6%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 13, 2026 2:58 AM ET
Data refreshes hourly during market hours. Next update: 3:58 AM
Data refreshes hourly during market hours. Next update: 3:58 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRRK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
David Hallal
SELL
30615 shares
2026-04-16
Keith Woods
SELL
10220 shares
2026-04-16
Vikas Sinha
SELL
10410 shares
2026-04-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
Advanced SRRK Option Strategies
Professional options setups generated by AI based on today's SRRK price and gamma walls.
